• A Venture Studio with Big Pharma Backing Seeks to Fix Drug Development with AI

  • Jun 13 2024
  • Duración: 1 h y 4 m
  • Podcast

A Venture Studio with Big Pharma Backing Seeks to Fix Drug Development with AI  Por  arte de portada

A Venture Studio with Big Pharma Backing Seeks to Fix Drug Development with AI

  • Resumen

  • Mati Gill, CEO of AION Labs, sits down with Amar Drawid to discuss how the AI venture studio works with its Big Pharma partners to define the biggest drug development hurdles the industry faces; and how it holds challenges to attract academics, entrepreneurs, and life sciences professionals with the best solutions to build new companies.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre A Venture Studio with Big Pharma Backing Seeks to Fix Drug Development with AI

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.